- Home
- Companies
- seychelles
- in vitro study
Refine by
In Vitro Study Suppliers Serving Seychelles
42 companies found
based inHanden, SWEDEN
BioThema developes, produces and sells reagents and kits for measuring ATP by the firefly luciferase reaction. Applications include rapid cell counting, cell proliferation and cytotoxicity, immunoassays, monitoring enzymes and metabolites, reporter ...
based inBrighton, UNITED KINGDOM
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. We have two exciting late-stage clinical assets and a range of earlier research programmes. Our ...
The XF drug platform has a novel, ultra-rapid mechanism that reduces the chance of bacteria becoming resistant to its action. Destiny Pharma’s XF platform has advantages over traditional antibiotics. ...
based inMontreal, QUEBEC (CANADA)
SCIREQ strives to make a strong impact on global pulmonary health by empowering scientists to better understand and eradicate lung diseases. The global burden of respiratory diseases is primarily driven by asthma, chronic obstructive pulmonary ...
based inTainan City, TAIWAN
Leadgene Biomedical Inc. is founded in 2013 and headquarters in Tainan, Taiwan. In the past years, we have become an all-around solution provider for proteomics study with more than thirty staff members from a three-scientists workshop, ...
based inHudson, MASSACHUSETTS (USA)
Proveris Scientific specializes in providing advanced instrument and laboratory services for testing solutions in the development and manufacturing of oral inhalation and nasal drug products (OINDP). They are recognized globally for their expertise ...
based inKrakow, POLAND
We are one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development. We have ...
Cell and Molecular Biology Department at Selvita performs In vitro comparative studies of biosimilar insulins and insulin analogs as well as battery of various therapeutic antibodies (e.g. TNFα, VEGF and HER2 ...
based inYuseong-gu, SOUTH KOREA
We strive to become a leading biotech company that contributes to human health and well-being by providing innovative therapeutic antibodies to patients with unmet medical needs. We have been committed to developing novel antibody therapeutics since ...
PMC-402 is a monoclonal antibody that targets the human TIE2 that regulated activation, proliferation, and repolarization of Tie2 expressing macrophages, resulting in T cell activation. It binds to TIE2 expressing macrophages that activate T cells ...
based inTrabzon, TURKEY
Dogsan, the first suture manufacturer of Turkey, Middle East and Balkan states, is founded in 1970 and have a long history in suture manufacturing. Competing with the global brands, Dogsan have gained its power from 45 year of expertise, almost 50 ...
PEGELAK sutures are synthetic absorbable sterile surgical sutures which are flexible strands composed of a copolymer prepared and synthesized from 90 percent glycolide and 10 percent L-lactide (derived from glycolic and lactic acids) and are ...
based inAlachua, FLORIDA (USA)
RTI Surgical (RTI) is a global, industry leading surgical implant supplier that provides design, new product development, processing and manufacturing services in support of patients and leading medical technology companies. With expertise in tissue ...
RTI Surgical offers the only meniscal allograft with both bone and meniscus sterilized through the BioCleanse® Tissue Sterilization Process. The BioCleanse processed meniscus graft provides a sterilized alternative to traditional aseptically ...
based inHillsborough, NEW JERSEY (USA)
LifeTein, located in Somerset, New Jersey, was founded in 2008 with a simple vision: understanding life sciences one protein at a time. This philosophy has formed the foundation of every peptide, protein, antibody, gene, and chemical project that we ...
based inGuildford, UNITED KINGDOM
Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys technology. Futura Medical is an innovative R&D company with a pipeline of products in late stage development. ...
Scientific advisory meeting held with MHRA confirming the need of a Phase 3 study to support the improved skin permeation including potential superior efficacy claims. Exploring the feasibility of a clinical study to satisfy the Phase 3 requirements ...
based inPipersville, PENNSYLVANIA (USA)
LAMPIRE specializes in custom polyclonal & monoclonal antibody development, secondary antibodies, IgGs, BSA, animal blood, tissues & organs, normal & disease state human serums & plasmas, cell media, OMNI C3 cell culture bags & contract ...
based inFlorham Park, NEW JERSEY (USA)
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and ...
We are developing CYNK-101 as a combination treatment for multiple cancer indications. CYNK-101 is manufactured from a specific type of immune cell, NK cells, that we extract from postpartum placentas and then genetically engineer to increase cell ...
based inCopenhagen, DENMARK
Cmbio specializes in advancements in microbiome science and multi-omics research, primarily focused on human, animal, and planetary health. With a team of over 100 experts in microbiology, bioinformatics, metabolomics, molecular biology, and data ...
based inLa Verpillière, FRANCE
As a world-leading drug delivery device solutions provider, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are a holistic partner and help our customers succeed in the sprint ...
Off-the-shelf devices available for key identified nasal drugs. Accelerate your sprint to market with our Device Equivalence Program. Based on FDA requirements, we have established a Device Equivalence Program in order to accelerate ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Mifepristone (RU486) is a progesterone receptor (PR) and glucocorticoid receptor (GR) antagonist with IC50s of 0.2 nM and 2.6 nM in in vitro ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
TP-0184 is an investigational inhibitor of activin receptor-like kinase 2 (ALK2) and ALK5 (also known as TGFβR1). This bimodal inhibitor is believed to downregulate multiple TGF-β superfamily signaling pathways and has shown antitumor ...
based inMilpitas, CALIFORNIA (USA)
BioVision, Inc., is a privately held Life Science company headquartered in the beautiful San Francisco Bay Area. BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other ...
based inPhiladelphia, PENNSYLVANIA (USA)
Allevi creates tools and solutions to design, engineer and build with life. Our 3D bioprinters and bioinks are used around the world to find solutions to humanity’s most difficult problems – to cure disease, to test novel drugs, and to eliminate the ...
based inSunnyvale, CALIFORNIA (USA)
JSR Life Sciences brings together the deep biochemical knowledge and understanding of human disease, expertise in drug discovery and development, and access to capital into a single, integrated framework that creates value for our customers. JSR ...